AORN Journal
AORNJournal
Add to My Podcasts
Episodes
About
Reviews
Promote
Janus kinase inhibitor therapy and venous thromboembolism risk factors
7 minutes
Posted Dec 24, 2022 at 1:08 pm.
0:00
7:30
Add to My Queue
Download
MP3
Share
episode
Share at current time
Show notes
Janus kinase inhibitor therapy and venous thromboembolism risk factors by AORNJournal
Previous
Identifying validated venous thromboembolism risk assessment tools
Next
Timing of the preoperative venous thromboembolism risk assessment
← See all 489 episodes of AORN Journal
